* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Notes on EMF affecting melatonin via nitric oxide
Point mutation wikipedia , lookup
Western blot wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Proteolysis wikipedia , lookup
Microbial metabolism wikipedia , lookup
Radical (chemistry) wikipedia , lookup
NADH:ubiquinone oxidoreductase (H+-translocating) wikipedia , lookup
Oxidative phosphorylation wikipedia , lookup
Biochemistry wikipedia , lookup
Enzyme inhibitor wikipedia , lookup
Catalytic triad wikipedia , lookup
Evolution of metal ions in biological systems wikipedia , lookup
Biosynthesis wikipedia , lookup
Metalloprotein wikipedia , lookup
Amino acid synthesis wikipedia , lookup
Notes on EMF affecting melatonin via nitric oxide Tryptophan Like Serotonin, precursor to melatonin. Another reason why mel suppressed? EMF– tryptophan–serotonin–melatonin http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1135961 Nitric oxide rapidly scavenges tyrosine and tryptophan radicals Biochem J. 1995 September 15; 310(Pt 3): 745–749. J P Eiserich, J Butler, A van der Vliet, C E Cross, and B Halliwell Department of Internal Medicine, University of California, Davis, 95616, USA. Abstract By utilizing a pulse-radiolytic technique, we demonstrate for the first time that the rate constant for the reaction of nitric oxide (.NO) with biologically relevant tyrosine and tryptophan radicals (Tyr. and Trp. respectively) in amino acids, peptides and proteins is of the order of (1-2) x 10(9) M-1.s-1. We also show that .NO effectively interferes with electron-transfer processes between tryptophan and tyrosine residues in proteins subjected to pulse radiolysis. The near diffusion-controlled rates of these reactions, coupled with the increasingly recognized role of protein radicals in enzyme catalysis and oxidative damage, suggest that Tyr. and Trp. are likely and important targets for .NO generated in vivo. EMF does not affect tryptophan directly. http://cat.inist.fr/?aModele=afficheN&cpsidt=3236057 Inactivation of brain tryptophan hydroxylase by nitric oxide Journal of neurochemistry (J. neurochem.) 1996, vol. 67, no3, pp. 1072-1077 (40 ref.) Kuhn D. M. (1 2) ; Arthur R. E. (1) Cellular and Clinical Neurobiology Program, Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, ETATSUNIS (2) Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, ETATS-UNIS (1) Abstract 81920136 1 Tryptophan hydroxylase, the initial and rate-limiting enzyme in the biosynthesis of the neurotransmitter serotonin, is inactivated by nitric oxide (NO) and by the NO generators sodium nitroprusside, diethylamine/NO, S-nitroso-N-acetylpenicillamine, and Snitrosocysteine. The inactivation occurs in an oxygen-free environment and is enhanced by dithiothreitol and ascorbic acid. Protection against the effect of NO on tryptophan hydroxylase is afforded by oxyhemoglobin, reduced glutathione, and exogenous Fe(II). Catalase partially protects the enzyme from NO-induced inactivation, whereas both superoxide dismutase and uric acid are without effect. These findings indicate that tryptophan hydroxylase is a target for NO and suggest that critical iron-sulfur groups in this enzyme serve as the substrate for NO-induced nitrosylation of the protein, resulting in enzyme inactivation. http://www.jbc.org/cgi/content/abstract/274/38/26907 J Biol Chem, Vol. 274, Issue 38, 26907-26911, September 17, 1999 Tryptophan 409 Controls the Activity of Neuronal Nitric-oxide Synthase by Regulating Nitric Oxide Feedback Inhibition (read carefully: could be important) Subrata AdakDagger , Carol CrooksDagger , Qian WangDagger , Brian R. Crane§, John A. Tainer§, Elizabeth D. Getzoff§, and Dennis J. StuehrDagger From the Dagger Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195 and the § Department of Molecular Biology and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037 The heme of neuronal nitric-oxide synthase participates in oxygen activation but also binds self-generated NO during catalysis resulting in reversible feedback inhibition. We utilized point mutagenesis to investigate if a conserved tryptophan residue (Trp-409), which engages in pi -stacking with the heme and hydrogen bonds to its axial cysteine ligand, helps control catalysis and regulation by NO. Surprisingly, mutants W409F and W409Y were hyperactive compared with the wild type regarding NO synthesis without affecting cytochrome c reduction, reductase-independent N-hydroxyarginine oxidation, or Arg and tetrahydrobiopterin binding. In the absence of Arg, NADPH oxidation measurements showed that electron flux through the heme was actually slower in the Trp-409 mutants than in wild-type nNOS. However, little or no NO complex accumulated during NO synthesis by the mutants, as opposed to the wild type. This difference was potentially related to mutants forming unstable 6-coordinate ferrous-NO complexes under anaerobic conditions even in the presence of Arg and tetrahydrobiopterin. Thus, Trp-409 mutations minimize NO feedback inhibition by preventing buildup of an inactive ferrous-NO complex during the steady state. This overcomes the negative effect of the mutation on electron flux and results in hyperactivity. Conservation of Trp-409 among different NOS suggests that the ability of this residue to regulate heme reduction and NO complex formation is important for enzyme physiologic function. http://www.jneurosci.org/cgi/content/abstract/17/19/7245 81920136 2 Volume 17, Number 19, Issue of October 1, 1997 pp. 7245-7251 Molecular Mechanism of the Inactivation of Tryptophan Hydroxylase by Nitric Oxide: Attack on Critical Sulfhydryls that Spare the Enzyme Iron Center Received May 27, 1997; revised July 14, 1997; accepted July 16, 1997. Donald M. Kuhn1, 2 and Robert Arthur Jr1 1 Cellular and Clinical Neurobiology Program, Department of Psychiatry and Behavioral Neurosciences, and 2 Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan 48201 Tryptophan hydroxylase (TPH), the initial and rate-limiting enzyme in the biosynthesis of the neurotransmitter serotonin (5-HT), is irreversibly inactivated by nitric oxide (NO). We have expressed brain TPH as a recombinant glutathione-S-transferase fusion protein and delineated the catalytic domain of the enzyme as the region spanning amino acids 99-444. Highly purified TPH catalytic core, like the native enzyme from brain, is inactivated by NO in a concentration-dependent manner. Removal of iron from TPH produces an apoenzyme with low activity that can be reconverted to its highly active holo-form by the addition of ferrous iron. Apo-TPH exposed to NO cannot be reactivated by iron. Treatment of holo-TPH (iron-loaded) with the disulfide 5,5'-dithio-bis (2-nitrobenzoic acid) (DTNB) causes an inactivation of TPH that is readily reversed by dithiothreitol (DTT). DTNB-treated TPH [sulfhydryl (SH)-protected] exposed to NO is returned to full activity by thiol reduction with DTT. The inactivation of native TPH by NO cannot be reversed by either iron or DTT. These data indicate that NO inactivates TPH by selective action on critical SH groups (i.e., cysteine residues) while sparing catalytic iron sites within the enzyme. The results are interpreted with reference to the substituted amphetamines, which are neurotoxic to 5-HT neurons, that inactivate TPH in vivo and are now known to produce NO and other reactive oxygen species in vivo. Serotonin http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids =10465443&dopt=Abstract Nitric oxide transforms neuromodulation. serotonin into an inactive form and this affects Fossier P, Blanchard B, Ducrocq C, Leprince C, Tauc L, Baux G. Laboratoire de Neurobiologie Cellulaire et Moleculaire, CNRS, Gif sur Yvette, France. Nitric oxide is a highly reactive molecule, diffusible and therefore ubiquitous in the central nervous system. Consequently, nitric oxide or nitric oxide-derived nitrogen oxides must enter into contact with neuromodulators and they can modify these molecules, especially monoamines, and thus change their regulatory action on synaptic transmission. We tested this possibility on a well-known, identified cholinergic synapse of Aplysia buccal ganglion, in which we have found that evoked acetylcholine release was decreased 81920136 3 by extracellularly applied serotonin. We show that this modulatory effect of serotonin was largely reduced not only in the presence of 3-morpholinosydnonimine, a nitric oxide donor, but also when endogenous nitric oxide synthase was activated. We have shown that this decrease in the serotonin effect is due to the formation of chemical derivatives of serotonin, mainly a symmetric serotonin dimer, 4-nitroso-serotonin and 4-nitro-serotonin, which are ineffective in reproducing the modulatory effect of serotonin. Serotonin is involved in the regulation of several central functions, such as sleep-wake activity or mood. The consequences of chemical modifications of serotonin by nitric oxide must be taken into account in physiological as well as pathological situations. In addition, our results highlight the importance of the physiological implications of interactions between free radicals and neuromediators in the nervous system. 81920136 4